Organization and Strategy at Millennium (B) Harvard Case Solution & Analysis

This case scrutinizes Millennium's organizational and tactical reactions to the fast progress of the biopharmaceutical market. In the early 2000s, as Millennium's competitive benefit in early-stage research study escaped and its losses installed, creator CEO Mark Levin moved the company downstream far from research study and to drug advancement and commercialization, at the same time narrowing horizontal breadth from greater than a dozen therapeutic classes to merely three.
Organization and Strategy at Millennium (B) Case Solution

In year 2005, Levin worked with Deborah Dunsire from Novartis as CEO to lead Millennium's continuing change. Apprentices are asked to position themselves in the shoes of inbound CEO Dunsire and to supply organizational proposals to carry out the brand-new approach.

PUBLICATION DATE: February 02, 2010 PRODUCT #: 710418-PDF-ENG

This is just an excerpt. This case is about STRATEGY & EXECUTION

Organization and Strategy at Millennium (B) Case Solution Other Similar Case Solutions like

Organization and Strategy at Millennium (B)

Share This